Association of Free Fatty Acids With Long‐Term Adverse Outcomes in Patients With Premature Myocardial Infarction: A Prospective Cohort Study

Background The dose–response relationship and independent prognostic value of free fatty acids (FFA) for major adverse cardiovascular events (MACE) in patients with premature myocardial infarction are not well established. This study aimed to evaluate the impact of FFA levels on long‐term outcomes and their combined effects with inflammatory markers, obesity, and insulin resistance. Methods This prospective cohort study enrolled 1168 consecutive patients with premature myocardial infarction admitted to the coronary care unit ward of Tianjin Chest Hospital from March 2017 to December 2024. Participants were categorized into 4 groups (Q1–Q4) by baseline FFA quartiles. Over a median follow‐up of 2.83 years (interquartile range, 2.58–3.10), the primary end point was MACE. Cox proportional hazards models and restricted cubic splines were used to assess associations and nonlinear relationships between FFA levels and MACE risk. Results FFA levels showed a U‐shaped association with long‐term prognosis in patients with premature myocardial infarction. Using Q2 (0.43–0.61 mmol/L) as reference, adjusted hazards for MACE were significantly higher in Q1 (hazard ratio [HR], 1.89 [95% CI, 1.11–2.96], P=0.009), Q3 (HR, 2.47 [95% CI, 1.55–3.93], P<0.001), and Q4 (HR, 2.94 [95% CI, 1.86–4.65], P<0.001). Joint analyses indicated synergistic risks increased when abnormal FFA coexisted with hs‐CRP (high‐sensitivity C‐reactive protein) >5 mg/L, body mass index >28 kg/m2, or triglyceride‐glucose index >9.21 mmol/L. Conclusions Both elevated and decreased FFA levels independently increase MACE risk in patients with premature myocardial infarction. Abnormal FFA levels combined with high inflammation, obesity, and insulin resistance significantly increase the risk of MACE, highlighting their combined value in the long‐term poor prognosis.

• Publication year

  2025

• Venue

  Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease

• Publication date

  2025-10-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/JAHA.125.042855PMID 41128147PMCID 12684601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events

  2025cited by this paper
• Report on Cardiovascular Health and Diseases in China 2023: An Updated Summary.

  2024cited by this paper
• The U -shape relationship between free fatty acid level and adverse outcomes in coronary artery disease patients with hypertension: evidence from a large prospective cohort study

  2024cited by this paper
• Free fatty acids and mortality among adults in the United States: a report from US National Health and Nutrition Examination Survey (NHANES)

  2024cited by this paper
• Free fatty acids induce coronary microvascular dysfunction via inhibition of the AMPK/KLF2/eNOS signaling pathway

  2023cited by this paper
• Associations Among Microvascular Dysfunction, Fatty Acid Metabolism, and Diabetes

  2023cited by this paper
• Decreased free fatty acid levels associated with adverse clinical outcomes in coronary artery disease patients with type 2 diabetes: Findings from the PRACTICE study.

  2023cited by this paper
• Impact of Metabolic Syndrome and Its Components on Clinical Severity and Long-Term Prognosis in Patients With Premature Myocardial Infarction

  2022cited by this paper
• Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review.

  2022cited by this paper
• Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease

  2021cited by this paper
• Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome.

  2021cited by this paper
• Enhancing Fatty Acids Oxidation via L-Carnitine Attenuates Obesity-Related Atrial Fibrillation and Structural Remodeling by Activating AMPK Signaling and Alleviating Cardiac Lipotoxicity

  2021cited by this paper
• Trends and Inequalities in the Incidence of Acute Myocardial Infarction among Beijing Townships, 2007–2018

  2021cited by this paper
• Distinct mechanisms involving diacylglycerol, ceramides, and inflammation underlie insulin resistance in oxidative and glycolytic muscles from high fat-fed rats

  2021cited by this paper
• Incidence, risk factors and outcome of young patients with myocardial infarction

  2020cited by this paper
• Palmitate-induced toxicity is associated with impaired mitochondrial respiration and accelerated oxidative stress in cultured cardiomyocytes: The critical role of coenzyme Q9/10.

  2020cited by this paper
• Non‐Esterified Fatty Acids and Risks of Frailty, Disability, and Mobility Limitation in Older Adults: The Cardiovascular Health Study

  2020cited by this paper
• Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study

  2019cited by this paper
• Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status

  2019cited by this paper
• Palmitate decreases migration and proliferation and increases oxidative stress and inflammation in smooth muscle cells: role of the Nrf2 signaling pathway.

  2019cited by this paper
• Modifiable Risk Factors in Young Adults With First Myocardial Infarction.

  2019cited by this paper
• PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression

  2019cited by this paper
• Augmentation of Glucotoxicity, Oxidative Stress, Apoptosis and Mitochondrial Dysfunction in HepG2 Cells by Palmitic Acid

  2019cited by this paper
• Serum concentrations of free fatty acids are associated with 3-month mortality in acute heart failure patients

  2019cited by this paper
• Metabolic remodeling of substrate utilization during heart failure progression

  2018cited by this paper
• Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

  2018cited by this paper
• Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

  2018cited by this paper
• Sensitivity Analysis in Observational Research: Introducing the E-Value

  2017cited by this paper
• Free fatty acid as an outcome predictor of atrial fibrillation–associated stroke

  2016cited by this paper
• High-fat diet induces endothelial dysfunction through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS pathway.

  2015cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.

  2014cited by this paper
• Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding

  2013cited by this paper
• Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study.

  2012cited by this paper
• Inflammatory response of human coronary artery endothelial cells to saturated long-chain fatty acids.

  2011cited by this paper
• Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease.

  2006cited by this paper
• Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases--report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults.

  2002cited by this paper

• The impact of obesity-related systemic inflammation on the efficacy, toxicity, and biomarkers of immune checkpoint inhibitors in lung cancer: from mechanisms to clinical management.

  2026cites this paper